NasdaqGM - Delayed Quote • USD
Wave Life Sciences Ltd. (WVE)
At close: 4:00 PM EDT
After hours: 4:03 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 5,300,000 | 3 |
| Sales | 15,630 | 1 |
| Net Shares Purchased (Sold) | 5,284,370 | 4 |
| Total Insider Shares Held | 22.26M | -- |
| % Net Shares Purchased (Sold) | 31.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MORAN KYLE Chief Financial Officer | Sale at price 6.17 per share. | Direct | 96,421 | Apr 3, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.16 per share. | Indirect | 4,160,000 | Dec 11, 2023 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.16 per share. | Indirect | 4,160,000 | Dec 11, 2023 |
| GLAXOSMITHKLINE PLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.00 per share. | Indirect | 16,500,000 | Dec 7, 2023 |
| MORAN KYLE Chief Financial Officer | Sale at price 4.75 per share. | Direct | 176,119 | Aug 23, 2023 |
| MORAN KYLE Chief Financial Officer | Sale at price 4.04 per share. | Direct | 39,305 | Feb 16, 2023 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 4.04 per share. | Direct | 118,776 | Feb 16, 2023 |
| VARGEESE CHANDRA Chief Technology Officer | Sale at price 4.03 per share. | Direct | 41,303 | Feb 16, 2023 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 4.03 per share. | Direct | 41,340 | Feb 16, 2023 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.15 per share. | Indirect | 20,382,112 | Jun 16, 2022 |
| MORAN KYLE Chief Financial Officer | Sale at price 1.72 per share. | Direct | 8,636 | May 5, 2022 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 1.72 per share. | Direct | 57,622 | May 5, 2022 |
| VARGEESE CHANDRA Chief Technology Officer | Sale at price 1.72 per share. | Direct | 28,748 | May 5, 2022 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 1.72 per share. | Direct | 18,691 | May 5, 2022 |
| PANZARA MICHAEL A Officer | Sale at price 1.72 per share. | Direct | 28,748 | May 5, 2022 |
| MORAN KYLE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 4, 2022 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 4, 2022 |
| VARGEESE CHANDRA Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 4, 2022 |
| FRANCIS CHRISTOPHER JOHN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 4, 2022 |
| PANZARA MICHAEL A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 4, 2022 |
| MORAN KYLE Chief Financial Officer | Sale at price 2.90 per share. | Direct | 26,692 | Feb 16, 2022 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 2.32 per share. | Direct | 76,908 | Feb 16, 2022 |
| VARGEESE CHANDRA Chief Technology Officer | Sale at price 2.32 per share. | Direct | 24,599 | Feb 16, 2022 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 2.90 per share. | Direct | 29,357 | Feb 16, 2022 |
| PANZARA MICHAEL A Officer | Sale at price 2.90 per share. | Direct | 30,749 | Feb 16, 2022 |
| MORAN KYLE Chief Financial Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 27,106 | Mar 24, 2021 |
| MORAN KYLE Chief Financial Officer | Sale at price 10.57 per share. | Direct | 18,202 | Feb 16, 2021 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 10.57 per share. | Direct | 118,437 | Feb 16, 2021 |
| VARGEESE CHANDRA Chief Technology Officer | Sale at price 10.57 per share. | Direct | 33,243 | Feb 16, 2021 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 10.57 per share. | Direct | 28,518 | Feb 16, 2021 |
| PANZARA MICHAEL A Officer | Sale at price 10.57 per share. | Direct | 30,960 | Feb 16, 2021 |
| MORAN KYLE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2021 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2021 |
| VARGEESE CHANDRA Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2021 |
| FRANCIS CHRISTOPHER JOHN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2021 |
| PANZARA MICHAEL A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2021 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 15.00 per share. | Direct | 1,500,000 | Sep 15, 2020 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 248,000 | Sep 15, 2020 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 12.00 per share. | Direct | 300,000 | Aug 25, 2020 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 62,000 | Aug 25, 2020 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 10.26 - 10.91 per share. | Direct | 1,520,276 | Jul 2, 2020 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 248,000 | Jul 2, 2020 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 7.85 per share. | Direct | 89,890 | Feb 18, 2020 |
| VARGEESE CHANDRA Officer | Sale at price 7.85 per share. | Direct | 25,026 | Feb 18, 2020 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 7.85 per share. | Direct | 21,258 | Feb 18, 2020 |
| PANZARA MICHAEL A Officer | Sale at price 7.85 per share. | Direct | 23,401 | Feb 18, 2020 |
| GAIERO DAVID G Chief Financial Officer | Sale at price 7.00 per share. | Direct | 4,557 | Feb 3, 2020 |
| VARGEESE CHANDRA Officer | Sale at price 35.00 per share. | Direct | 210,000 | Dec 3, 2019 |
| VARGEESE CHANDRA Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 14,880 | Dec 3, 2019 |
| VERDINE GREGORY L Director | Sale at price 30.27 - 32.74 per share. | Direct | 920,213 | Nov 20, 2019 |
Related Tickers
PRQR ProQR Therapeutics N.V.
1.9900
+6.99%
ARWR Arrowhead Pharmaceuticals, Inc.
22.33
-1.24%
KRRO Korro Bio, Inc.
66.74
-0.06%
PEPG PepGen Inc.
10.54
-11.06%
PRME Prime Medicine, Inc.
4.5100
-1.74%
AVTE Aerovate Therapeutics, Inc.
22.05
+2.08%
SRRK Scholar Rock Holding Corporation
13.85
-0.72%
ALNY Alnylam Pharmaceuticals, Inc.
144.41
-0.52%
VRDN Viridian Therapeutics, Inc.
14.60
-3.69%
ATXS Astria Therapeutics, Inc.
9.75
-7.50%